StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Bank of America lowered shares of FibroGen from a neutral rating to an underperform rating and dropped their price objective for the stock from $4.00 to […]
More Stories
6 More Fraud Suspects Indicted in Minnesota, as $18 Billion in Medicaid Billing Is Reviewed
By Janice Hisle U.S. First Assistant Attorney Joe Thompson announced indictments against a half-dozen new suspects in a pair of...
Trump Gives Federal Workers 2 More Days Off: Dec. 24 and 26
By Jackson Richman WASHINGTON—President Donald Trump signed an executive order on Thursday closing the federal government on Dec. 24 and...
Trump Media to Merge With Nuclear Fusion Company TAE in $6 Billion Deal
By Tom Ozimek President Donald Trump’s media company, Trump Media & Technology Group (TMTG), said on Dec. 18 that it...
Trump Announces $1,776 ‘Warrior Dividends’ to Military Members
By Jacob Burg President Donald Trump on Dec. 17 announced that more than a million military service members will receive...
Inflation Cools to 2.7 Percent in November, Lower Than Expected
By Andrew Moran Price pressures may be cooling across the economy, with the 12‑month inflation rate slowing sharply in November....
FAA Says It Will Commit $6 Billion to Air Traffic Control Modernization by Dec. 31
By Jacob Burg The Federal Aviation Administration (FAA) plans to commit $6 billion by the end of the year to...